<DOC>
	<DOCNO>NCT01327352</DOCNO>
	<brief_summary>The study non-randomized , open label , single dose , placebo control , single center , single arm study healthy subject . The study include one administration placebo four single administration Oshadi D two different dose level , administer two feed regimen evaluation influence food Oshadi D absorption .</brief_summary>
	<brief_title>Evaluation Influence Food Regimen Oshadi D Absorption</brief_title>
	<detailed_description />
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<criteria>Healthy Male/female 21 year old . Subject must understand willing give write informed consent prior study procedure evaluation willing adhere study schedule requirement . Subject must sterile infertile use approve method contraception time first dose study medication take three month follow study completion discontinuation . Any history significant cardiac , renal , neurologic , metabolic , pulmonary , gastrointestinal , hematologic abnormality , chronic hepatic disease disease judgment investigator would interfere study confound result . Subject positive HIV serology positive HBsAg screening . History evidence active liver disease . Female subject breastfeed positive pregnancy test screening time study . Inability give write informed consent History alcohol drug abuse within 6 month screen . Subject positive urine drug screen substance abuse ( benzodiazepine , THC , opiates , amphetamine , cocaine ) screening . Mental disorder . Subject poor venous access Significant swallowing disorder Digestive disorder ; Small bowel surgery ; Mall absorption disorder .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>lupus</keyword>
</DOC>